
Iovance Biotherapeutics, Inc. Common Stock
IOVA
IOVA: Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approval and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
moreShow IOVA Financials
Recent trades of IOVA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IOVA's directors and management
Government lobbying spending instances
-
$170,000 Mar 14, 2023 Issue: Medicare/Medicaid
-
$260,000 Jan 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$260,000 Oct 11, 2022 Issue: Medicare/Medicaid Health Issues
-
$260,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$50,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jul 19, 2021 Issue: Health Issues
-
$40,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Apr 19, 2021 Issue: Health Issues
-
$30,000 Jan 21, 2021 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2021 Issue: Health Issues
New patents grants
-
Patent Title: Processes for generating til products enriched for tumor antigen-specific t-cells Aug. 01, 2023
-
Patent Title: Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion Jun. 06, 2023
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy May. 16, 2023
-
Patent Title: Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy Apr. 18, 2023
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Jan. 03, 2023
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Dec. 20, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Dec. 06, 2022
-
Patent Title: Methods of using tumor infiltrating lymphocytes in double-refractory melanoma Sep. 06, 2022
-
Patent Title: Remnant tumor infiltrating lymphocytes and methods of preparing and using the same Aug. 02, 2022
-
Patent Title: Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy Jul. 12, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jun. 28, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jun. 21, 2022
-
Patent Title: Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof Jun. 14, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jun. 07, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jun. 07, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes May. 31, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes May. 31, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy May. 31, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy May. 24, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Apr. 26, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Apr. 19, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Apr. 19, 2022
-
Patent Title: Remnant tumor infiltrating lymphocytes and methods of preparing and using the same Apr. 05, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Apr. 05, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 15, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 15, 2022
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Mar. 08, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Feb. 22, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Feb. 08, 2022
-
Patent Title: Remnant tumor infiltrating lymphocytes and methods of preparing and using the same Jan. 11, 2022
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Dec. 21, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Dec. 21, 2021
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Nov. 23, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Nov. 09, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Nov. 09, 2021
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Oct. 12, 2021
-
Patent Title: Programmed death 1 ligand 1 (pd-l1) binding proteins and methods of use thereof Oct. 12, 2021
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Sep. 21, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Aug. 10, 2021
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jul. 13, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Jul. 06, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Jul. 06, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Jun. 22, 2021
-
Patent Title: Restimulation of cryopreserved tumor infiltrating lymphocytes Jun. 08, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy May. 25, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy May. 18, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 23, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 23, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 16, 2021
-
Patent Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Mar. 16, 2021
Federal grants, loans, and purchases
Followers on IOVA's company Twitter account
Number of mentions of IOVA in WallStreetBets Daily Discussion
Recent insights relating to IOVA
Recent picks made for IOVA stock on CNBC
ETFs with the largest estimated holdings in IOVA
Flights by private jets registered to IOVA